Gestational diabetes: a reappraisal of HBA1c as a screening test
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent technological advances have made HBA1c a more standardized and user-friendly test with wide availability. This study evaluated HBA1c as a screening test for gestational diabetes mellitus (GDM) in a high-risk population. METHODS: A total of 442 pregnant women were assessed by HBA1c. Two thresholds were used to "rule in or rule out" GDM, which was confirmed by the "gold-standard" 75-g OGTT (World Health Organization criteria). RESULTS: Eighty-four (19%) women had GDM while 358 (81%) women were normal; there was a complete overlap of the HBA1c histograms of the two populations. The area under receiver operating characteristic curve of HBA1c to detect GDM was 0.54 (95% CI 0.48-0.61). Using a value of <5.5% to rule out GDM; a sensitivity of 82.1% was achieved, with 15 (16.7%) of 90 women below the threshold being false-negatives (NPV = 83.3%). Using a threshold of HBA1c > or = 7.5% to rule-in GDM; the specificity was 95.8% with 15 (71.4%) of 21 patients over the threshold being false-positives (PPV = 28.6%). HBA1c would eliminate the need for an OGTT in 25.1% (111/442) of whom 27% (30/111) women would be misclassified. At any HBA1c threshold with an acceptable sensitivity, the false-positive rate remained high making it necessary for too many healthy women to undergo the confirmatory OGTT. CONCLUSION: Despite all the progress in methodology, HBA1c remains a poor test to screen for GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Greiner, M., Pfeiffer, D., & Smith, R. D. (2000) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(00)00115-x · Cited by 1,923
Screening criteria for high-risk gestational diabetic patients
O'Sullivan, J. B., Mahan, C. M., Charles, D., & Dandrow, R. V. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33833-9 · Cited by 478 · cited 1×
“The original study showed a sensitivity of 79% and a false-positive rate of 13% (12).”
BackgroundBrody, S. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)03057-0 · Cited by 200 · cited 4×
“It is generally accepted that screening for GDM should be done; there are a range of recommended strategies and tests (2) but the optimal approach to screening remains uncertain (1).”
BackgroundResultInfluential
Cited by
Donovan, L., Hartling, L., Muise, M., Guthrie, A., Vandermeer, B., & Dryden, D. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00657 · Cited by 125
“2 mmol/L [ 130 mg/dL]) (8, 9, 26), ADA (75-g glucose dose) (2000–2010 criteria) (35, 51, 55), Canadian Diabetes Association (37), and WHO (21, 29, 32).”
Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011059 · Cited by 86
Al-Rifai, R. H., Abdo, N. M., Paulo, M. S., Saha, S., & Ahmed, L. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.668447 · Cited by 78
Frequent monitoring of A1c during pregnancy as a treatment tool to guide therapy
Jovanovič, L., Savas, H., Mehta, M., Trujillo, A., & Pettitt, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1455 · Cited by 60
Ho, Y.-R., Wang, P., Lu, M.-C., Tseng, S.-T., Yang, C.-P., & Yan, Y.-H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177563 · Cited by 59
Metadata
- Authors
- Agarwal, M. M., Dhatt, G. S., Punnose, J., & Koster, G.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 84
- Issue
- 12
- Pages
- 1159-1163
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2045958315
- Cited by
- 77
- References
- 4
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gestational diabetes: a reappraisal of HBA1c as a screening test. https://app.cochat.ai/papers/10.1080/j.0001-6349.2005.00650.x
- The paper
- Agarwal, M. M., Dhatt, G. S., Punnose, J., & Koster, G. (2005). Gestational diabetes: a reappraisal of HBA1c as a screening test. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1080/j.0001-6349.2005.00650.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.